Connect with us

Stocks

Earnings ‘break the tie’ between tariffs, growth

Published

on


As CNBC’s Jim Cramer sees it, the stock market is in the middle of a full-fledged stand-off between the bulls and the bears.

The bulls got a win with Friday morning’s jobs report from the U.S. Labor Department that said the country added 213,000 non-farm jobs in June. Stocks rose after the report was issued.

But the bears were already reeling from the official start of the U.S.-China trade war that came just after midnight on Friday, in which the two nations exchanged $34 billion worth of tariffs.

And while Cramer was astonished by how many jobs were being created without a serious uptick in inflation, he couldn’t get too bullish considering the damage that tariffs could still do to the U.S. economy.

“I’ve said many times that trade is a tough issue and we may need to accept some short-term pain if we’re going to ever get our trading partners to play fair. But for the moment, that short-term pain does hurt,” the “Mad Money” host said Friday.

“So is our economy strong enough to keep on trucking even in the face of these negatives? I think we’ll get some real insight into that as companies start reporting next week,” he said.

With those opposing forces in mind, Cramer turned to his weekly game plan:



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stocks

Gilead and Celgene’s stocks may have more room to run

Published

on

By


CNBC’s Jim Cramer was somewhat surprised to see the biotechnology sector bounce back in 2018 after months of weakness.

“At a time when President Trump keeps slamming the pharmaceutical industry over excessive drug pricing, … you might think that the biotech stocks should be getting slaughtered,” the “Mad Money” host said on Tuesday.

“But you know what? After spending a long time in the doghouse, biotech as a whole is actually having a pretty darned good year, with the Nasdaq Biotechnology ETF, the IBB, up 17 percent for 2018,” he continued.

To make sense of the biotech stocks’ new leadership role, Cramer brought in technician Bob Lang, the founder of ExplosiveOptions.net and part of TheStreet.com’s Trifecta Stocks newsletter team.

Lang, who uses technical tools to track the action in particular stocks, decided to look at the group’s most recent leaders and laggards, beginning with the daily chart of Gilead Sciences.

Since Gilead went out of style on Wall Street in 2015 for curing Hepatitis C — a feat that, somewhat ironically, investors figured would lead to less recurrent business for Gilead — its stock has been pummeled.

But Lang noted that in the last few months, particularly after Gilead’s $11.9 billion acquisition of cancer immunotherapy play Kite Therapeutics, its stock has been bouncing, logging higher highs and higher lows.

Gilead’s stock has managed to break through its 50- and 200-day moving averages as well as its former ceiling of resistance, and key momentum indicators like the Relative Strength Index have surged into positive territory, Lang said.

Better yet, Gilead’s moving average convergence-divergence indicator, which technicians use to predict changes in a stock’s trajectory, recently made a very bullish crossover, telling Lang that the stock could be prime for a rally.

“The stock is overbought right here and the next ceiling comes in at around $82, up $5 bucks from these levels, but given everything else he sees in the chart, Lang believes Gilead can keep climbing,” Cramer said. “In fact, it’s his favorite name in the group and he wouldn’t be surprised if it starts challenging its old highs of around $110 by the end of the year.”

Next, Lang turned to the daily chart of Celgene, a biopharmaceutical giant with a focus on treating cancer and inflammatory disorders.

Shares of Celgene are down 20 percent for 2018 because of concerns about its leading drug, Revlimid, and the rest of its pipeline. But, like Gilead, the stock has been making a comeback in recent weeks.

Lang started by inspecting Celgene’s Chaikin Money Flow, which measures levels of buying and selling pressure in a stock. Not long ago, this indicator turned green, indicating to Lang that institutional buyers were warming up to the stock. He added that the stock has made a “W” formation of late — another bullish signal.

“Right now, the stock’s at $86. [Lang] thinks it could make a move to the 200-day moving average, … currently around $97 bucks, in the coming weeks,” Cramer said. “He may be right given the recent rotation into biotech. Without the rotation, though, I’m less sanguine.”

Lang also threw a third name into the mix — Illumina, a biotech-oriented medical technology company that builds machines for DNA analysis with one of the best-performing big-cap health-care stocks since 2017.

“As far as Lang’s concerned, the chart is a thing of beauty,” Cramer said, noting the stock’s steady climb, “robust” Chaikin Money Flow and “insanely strong” moving average convergence-divergence indicator.

The only issue seemed to be that the stock was overbought, but that didn’t shake Cramer or Lang.

“This thing, though, has been overbought very frequently since 2017. Now, that has never been a reason to sell the stock,” the “Mad Money” host said. “Instead, you’ve done much better if you simply wait for the next pullback — and we get those all the time — and use that weakness to do some buying.”

Lang’s analysis echoed that point, recommending that investors use weakness in Illumina’s stock to buy and strength to sell.

“The biotechs and the biomed techs have finally started showing some signs of life and the charts, as interpreted by Bob Lang, suggest that Gilead, Celgene and Illumina have more room to run,” Cramer said. “My view? Look, if you believe the economy is going to stay strong, then maybe this rally does peter out, but you’ve got my blessing to put on some exposure on any one of these or all of them, as I think Lang is going to be dead right.”



Source link

Continue Reading

Stocks

The greatest obstacle to investing success is… you

Published

on

By


From Richard Smith, Founder, TradeStops:

If you’re like the average investor, you’d say it’s easy to feel overwhelmed at times by confusion in the markets – and sometimes even by fear.

But why should it have to be this way?

Investing is a noble pursuit. Generating wealth for a comfortable retirement means creating the financial freedom to live well in the golden years… while providing support to loved ones… enjoying the finer things in life… and possibly making a real difference in the world.

Those are all good things. The pursuit of good things should not be a stressed-out experience! But for too many investors, that’s exactly what it is. Their market journey is a series of obstacles and worries.

There is bad news and good news here.

First the bad news: Your greatest obstacle to investing success is… you.

And the good news: The solution to overcoming your “greatest obstacle” is within reach.

What does that mean, to say the greatest obstacle to investing success is you?

It means that when it comes to investing successfully, finding great stocks is not the hardest thing. And dealing with volatility is not the hardest thing.

The hardest thing for any investor  and this includes everyone from Warren Buffett on down  is overcoming the natural pitfalls and challenges within their own brains.

Walt Kelly, the artist who drew “Pogo,” had a caption on his most famous cartoon that read: “We have met the enemy, and he is us.”

undefined

That statement could have been tailor-made for investors. Your biggest challenge as an investor will be overcoming your natural behavioral shortfalls and biases  learning to do the right thing and overcoming your built-in bad behaviors in the process.

(And again, this isn’t just “you” specifically. It’s also true for me, and Warren Buffett, and everyone else.)

This really goes back to the essential mission of TradeStops. We want to help as many investors as possible find a path to comfortable retirement. (We’ve helped 25,000 so far, but that number should expand 1,000-fold.)

A key goal of TradeStops is to remove anxiety from the investment process, and in doing so, help investors rediscover the joy of investing as they build long-term wealth.

How do we do this? By combining science, technology, and proven principles of behavior modification.

To get rid of bad investing habits, you can’t conduct brain surgery on yourself (and you wouldn’t want someone else to try).

But you can use software as a tool in the investment decision-making process… which in turn serves as a form of painless behavior modification… which puts you on the path to anxiety-free investment success.

Again, this is what TradeStops is all about: Helping investors overcome their greatest obstacle to investing success… so they can meet their long-term wealth-building goals… and have a positive impact on everyone around them.

Here’s something else funny about the brain: Knowledge makes behavior modification easier.

The better and deeper the brain understands the “why” behind something, the easier it becomes to make a positive behavior change around that thing. And sometimes the “why” is even more important than the rules.

The importance of the “why” was once vividly demonstrated by Ed Seykota, a famous trend follower who made countless millions in the commodity futures markets.

Seykota was one of the earliest adopters of mechanical trend-following techniques. In the 1970s he was a pioneer in the use of exponential moving average crossover systems. (They were so new and exotic at the time, people called them “expedential” moving averages.)

At one point, Seykota decided to teach a classroom course on trend following. For the curious who signed up  remember, trend following was totally new at this point  Seykota spent something like 10 percent of the classroom time explaining the very simple rules of his trend-following system  and the other 90 percent explaining the “why” behind the importance of sticking with the rules!

We’ve realized a similar idea applies to TradeStops software.

No matter how good our software is  and you continue to give us rave reviews, for which we are deeply grateful – it feels like there is always more opportunity to help you, our customers and fellow investors, to get more out of TradeStopsby better understanding the “why” behind certain basic principles.

To that end, we are excited to start something new: An “education series” of editorials, designed to help you become a better investor by sharing the “why” behind some very important concepts.

Our game plan with the education series is to start with the following concepts, exploring each one over a period of weeks or months:

  • Cognitive Biases
  • Probability
  • Investor Psychology

We’re confident the insight you gain from this series can help make you a better investor, even if you aren’t currently using TradeStops. (Though of course, if you haven’t yet experienced the power of TradeStops, we suggest rectifying that immediately!)

Another one of our goals for 2018 is to accelerate the development of TradeSmith University, our ongoing effort to enhance your education as an investor. It goes back to the same set of goals: Giving you more of the “why” behind the principles of investing… so you can make better use of the TradeStops software… in order to reach your wealth-building retirement goals.

It’s an exciting project. We’ve got some great material to draw from, and we’re confident you’ll learn a lot.

If you have any questions, comments, or just something you’ve always wanted to know about cognitive biases, probability, or investor psychology, let us know!

undefined

Richard

Crux note: Richard’s TradeStops philosophy is to cut your losses and let your winners ride… And the results speak for themselves.

You can discover why one satisfied investor called TradeStops his “safety net” right here.


×
Subscribe to Crux



Source link

Continue Reading

Stocks

Two things the World Cup can teach you about investing

Published

on

By


From Jason Bodner, Editor, Palm Beach Trader:

Last week, my phone had a temper tantrum. It just wouldn’t work and was so slow that I couldn’t take it. I took it to the phone store to see my upgrade options.

I brought my three sons. While I waited to get a new phone, they watched the World Cup game in the store.

I wasn’t paying attention, but my seven-year-old Liam proudly proclaimed that Belgium was playing Japan.

This was big deal. (And in a moment, I’ll tell you how it all relates to investing.)

You see, my wife was born and raised in a small city in Belgium. My kids all have dual citizenship. I’m the only one in the family who has just a U.S. passport.

When we left the store, the score was 0-0 at halftime. We were still confident our team would win. There was talk of how Belgium could go all the way. We seemed a sure bet against Japan. (Belgium lost to France in the semifinals on Tuesday.)

About 20 minutes later in the car, I asked Sacha, my middle son, to tell me the score…

Belgium was down by two goals and still hadn’t scored. It was quickly turning into one of the biggest upsets in World Cup history.

Sacha was bummed, but being an optimist said, “You never know… We can come back. It’s not over yet!”

I saw his face was mixed with disappointment and hope. I replied with a weak moment of adult realism: “I don’t know Sach, it seems doubtful. Sorry dude.”

I felt bad the way a dad does when he’s gotta break bleak reality to his kid.

Five minutes later, he said “Oh yeah, Daddy? Look now!” I nearly crashed the car when I saw on his phone that the score was now 2-2. I was screaming with glee with the windows open. It must have looked strange to anyone standing on the street.

When I got home, we ran into the house to watch the final minutes of the game. Belgium scored an injury-time goal to win 3-2.

My sons and I started jumping around. Belgium turned what would have been the biggest upset in the World Cup into the biggest comeback.

Aside from being a fantastic game, there is a point to this story…

You see, I was ready to throw in the towel on Belgium. Psychologically, I had given up.

There was plenty of time for a comeback – improbable as it was. But my mind had written off that possibility and given in to despair.

Sure enough, I was dead wrong. And that’s the point…

Emotion is the true enemy of investors. It can lead to despair and fear. And that can cause you to make drastically wrong decisions.

If Belgium were a stock, emotion would have told me, “I can’t take it anymore!”

I would have sold at the exact bottom.

It took me a long time to learn how to overcome emotion as an investor. Ultimately, the most important thing I had to master was my own mind.

Like most people, I have a knack for doing the wrong thing at the worst moment when I act based on emotion. That’s why I built a stock investing system to take guesswork and emotion out of it.

Your stock positions will move up and down, day-to-day, and week-to-week. The market itself will get bumpy from time to time. We all know this… Yet we still act on our feelings when it happens.

The key to overcoming emotion is to stay rational – especially when things get bumpy.

There are two ways I do this:

  • Stay patient. I need to remind myself that investing in stocks is a long-term game. I need to stick to my system and not sell out of fear.
  • Stay focused. When I feel overwhelmed by emotion, I find it helpful to take a walk or do something to focus my attention on something other than what’s bothering me. For me, listening to music or walking my dogs calms me down and helps me refocus.

Emotions cause us to react. Logic dictates that we stay disciplined. Patience and focus will get us to where we want to be.

Talk soon,

undefined

Jason

Crux note: In case you missed it…

Palm Beach‘s crypto expert Teeka Tiwari is teaming up with political commentator and radio host Glenn Beck to create a one-off special extended broadcast live from his studio in Dallas: The Great Cryptocurrency Conspiracy of 2018.

Tune in July 19 at 8 p.m. Eastern time to discover the secret behind making money with cryptos like bitcoin – something both Wall Street and Washington would like to keep hidden from you…

Click here to register for this free event.


×
Subscribe to Crux



Source link

Continue Reading

Trending

Copyright © 2017 Zox News Theme. Theme by MVP Themes, powered by WordPress.